NPPES file of Aug 9, 2026

Michael S. Balkin, MD

Endocrinology, Diabetes & Metabolism Physician · Huntington, NY

Michael S. Balkin, MD is an endocrinology, diabetes & metabolism physician with a practice address in Huntington, New York, and NPI 1861565780, issued on Nov 16, 2006. Check the license (New York 120257, as entered in NPPES) on the NYS Education Department, Office of the Professions; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1861565780
Name
Michael S. Balkin
Credential
MD
Primary taxonomy
Endocrinology, Diabetes & Metabolism Physician 207RE0101X
License number
120257 NY
Self-reported in NPPES; status is on the state search
Practice location
191 East Main Street, Huntington, NY 11743
Phone
(631) 549-2525
Enumerated
Nov 16, 2006
Record last updated
Jan 30, 2015 (not updated in 11 years: call before relying on the address or phone)
Fax
(516) 432-2831
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 191 East Main Street

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Charles Romano, DPMPodiatrist1801973300

Verify Michael S. Balkin in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersNYS Education Department, Office of the Professions
    Search for license 120257
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the New York license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

66% fewer Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024

891 Medicare Part D claims for 73 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 40% of claims.

  1. Michael Balkin891
  2. Specialty average2,630

Most prescribed

  1. Levothyroxine Sodium112 claims
  2. Rosuvastatin Calcium63 claims
  3. Mounjaro51 claims
  4. Jardiance43 claims
  5. Synthroid39 claims
  6. Alendronate Sodium31 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Michael S. Balkin among 970 endocrinology, diabetes & metabolism physician records in New York

Michael S. Balkin, MD is one of 970 endocrinology, diabetes & metabolism physician records with a practice address in New York. 86% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 9% of them.

  • NPI issued2006 · 9% of these records are older, 57% newer
  • In a Medicare fileYes · 86% of these records are
  • In the CMS Doctors and Clinicians fileNo · 72% of these records are
  • Record last updated2015 · 59% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RE0101X and a New York practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Endocrinology, Diabetes & Metabolism Physician providers in New York

There are 970 endocrinology, diabetes & metabolism physician records in New York.

The 8 endocrinology, diabetes & metabolism physician records with the nearest ZIP codes

  1. Gary Trager, MDHuntington, NY 117431659442499
  2. Zimu Zheng, MDHuntington, NY 117431811054893
  3. Neha Arora, D.O.Greenlawn, NY 117401275953572
  4. Maria Davila, M.D.Greenlawn, NY 117401659643104
  5. Rachel Pessah Pollack, M.D.Huntington Station, NY 117461669632196
  6. John Tloczkowski, MDGreenlawn, NY 117401730402702
  7. Manali PraganiIslandia, NY 117491497335871
  8. Alan Chang, M.D.East Setauket, NY 117331649408675

Common questions

What is Michael S. Balkin, MD's NPI number?

Michael S. Balkin, MD's National Provider Identifier (NPI) is 1861565780, issued on Nov 16, 2006. An NPI identifies a provider in billing; it is not a license.

Where is Michael S. Balkin, MD located?

The NPPES record lists a practice address at 191 East Main Street, Huntington, NY, 11743. Phone: (631) 549-2525. Providers update this record themselves, so call before visiting.

How can I verify Michael S. Balkin, MD's license?

NPPES lists New York license number 120257, as entered by the provider. Search the NYS Education Department, Office of the Professions at https://www.op.nysed.gov/services/verifications/online-verification-searches. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Michael S. Balkin, MD prescribe under Medicare Part D?

In 2024, Michael S. Balkin, MD had 891 Medicare Part D claims for 73 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.